mutLBSgeneDB |
Gene summary for ACAA2 |
Gene summary |
Basic gene Info. | Gene symbol | ACAA2 |
Gene name | acetyl-CoA acyltransferase 2 | |
Synonyms | DSAEC | |
Cytomap | UCSC genome browser: 18q21.1 | |
Type of gene | protein-coding | |
RefGenes | NM_006111.2, | |
Description | 3-ketoacyl-CoA thiolase, mitochondrialT1acetyl-Coenzyme A acyltransferase 2beta ketothiolasebeta-ketothiolasemitochondrial 3-oxoacyl-CoA thiolasemitochondrial 3-oxoacyl-Coenzyme A thiolase | |
Modification date | 20141207 | |
dbXrefs | MIM : 604770 | |
HGNC : HGNC | ||
HPRD : 10380 | ||
Protein | UniProt: P42765 go to UniProt's Cross Reference DB Table | |
Expression | CleanEX: HS_ACAA2 | |
BioGPS: 10449 | ||
Pathway | NCI Pathway Interaction Database: ACAA2 | |
KEGG: ACAA2 | ||
REACTOME: ACAA2 | ||
Pathway Commons: ACAA2 | ||
Context | iHOP: ACAA2 | |
ligand binding site mutation search in PubMed: ACAA2 | ||
UCL Cancer Institute: ACAA2 | ||
Assigned class in mutLBSgeneDB | C: This gene just belongs to mutLBSgenes. |
Gene ontology having evidence of Inferred from Direct Assay (IDA) from Entrez |
GO ID | GO Term | PubMed ID | GO:0071456 | cellular response to hypoxia | 18371312 | GO:1901029 | negative regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway | 18371312 | GO:1902109 | negative regulation of mitochondrial membrane permeability involved in apoptotic process | 18371312 |
Top |
Ligand binding site mutations for ACAA2 |
Cancer type specific mutLBS sorted by frequency |
LBS | AAchange of nsSNV | Cancer type | # samples | L152 | S151L | BLCA | 1 |
cf) Cancer type abbreviation. BLCA: Bladder urothelial carcinoma, BRCA: Breast invasive carcinoma, CESC: Cervical squamous cell carcinoma and endocervical adenocarcinoma, COAD: Colon adenocarcinoma, GBM: Glioblastoma multiforme, LGG: Brain lower grade glioma, HNSC: Head and neck squamous cell carcinoma, KICH: Kidney chromophobe, KIRC: Kidney renal clear cell carcinoma, KIRP: Kidney renal papillary cell carcinoma, LAML: Acute myeloid leukemia, LUAD: Lung adenocarcinoma, LUSC: Lung squamous cell carcinoma, OV: Ovarian serous cystadenocarcinoma, PAAD: Pancreatic adenocarcinoma, PRAD: Prostate adenocarcinoma, SKCM: Skin cutaneous melanoma, STAD: Stomach adenocarcinoma, THCA: Thyroid carcinoma, UCEC: Uterine corpus endometrial carcinoma. |
Top |
Protein structure related information for ACAA2 |
Relative protein structure stability change (ΔΔE) using Mupro 1.1 Mupro score denotes assessment of the effect of mutations on thermodynamic stability. (ΔΔE<0: mutation decreases stability, ΔΔE>0: mutation increases stability) |
: nsSNV at non-LBS: nsSNV at LBS |
nsSNVs sorted by the relative stability change of protein structure by each mutation Blue: mutations of positive stability change. and red : the most recurrent mutation for this gene. |
LBS | AAchange of nsSNV | Relative stability change | L152 | S151L | -0.48180415 |
(MuPro1.1: Jianlin Cheng et al., Prediction of Protein Stability Changes for Single-Site Mutations Using Support Vector Machines, PROTEINS: Structure, Function, and Bioinformatics. 2006, 62:1125-1132) |
Structure image for ACAA2 from PDB |
Top |
Differential gene expression and gene-gene network for ACAA2 |
Differential gene expression between mutated and non-mutated LBS samples in all 16 major cancer types |
Differential co-expressed gene network based on protein-protein interaction data (CePIN) |
Top |
Top |
Phenotype information for ACAA2 |
Gene level disease information (DisGeNet) |
Disease ID | Disease name | # PubMed | Association type |
umls:C0029408 | Osteoarthritis | 1 | Biomarker |
Mutation level pathogenic information (ClinVar annotation) |
Allele ID | AA change | Clinical significance | Origin | Phenotype IDs |
Top |
Pharmacological information for ACAA2 |
Gene expression profile of anticancer drug treated cell-lines (CCLE) Heatmap showing the correlation between gene expression and drug response across all the cell-lines. We chose the top 20 among 138 drugs.We used Pearson's correlation coefficient. |
Drug information targeting mutLBSgene (Approved drugs only) |
Drug status | DrugBank ID | Name | Type | Drug structure |
Gene-centered ligand-gene interaction network |
Ligands binding to mutated ligand binding site of ACAA2 go to BioLip |
Ligand ID | Ligand short name | Ligand long name | PDB ID | PDB name | mutLBS | COA | COENZYME A | 4c2j | B | L152 | COA | COENZYME A | 4c2j | D | L152 |
Top |
Conservation information for LBS of ACAA2 |
Multiple alignments for P42765 in multiple species |
LBS | AA sequence | # species | Species | A247 | DGTVTAGNASG | 2 | Homo sapiens, Mus musculus | A247 | EGTVTAGNASG | 2 | Rattus norvegicus, Bos taurus | A322 | VEVNEAFAPQY | 2 | Homo sapiens, Bos taurus | A322 | IDVNEAFAPQF | 2 | Mus musculus, Rattus norvegicus | C92 | TINRLCGSGFQ | 2 | Homo sapiens, Bos taurus | C92 | TLNRLCGSGFQ | 2 | Mus musculus, Rattus norvegicus | F323 | EVNEAFAPQYL | 2 | Homo sapiens, Bos taurus | F323 | DVNEAFAPQFL | 2 | Mus musculus, Rattus norvegicus | G248 | GTVTAGNASGV | 3 | Homo sapiens, Mus musculus, Bos taurus | G248 | GTVTAGNASGM | 1 | Rattus norvegicus | H352 | AIALGHPLGGS | 3 | Homo sapiens, Mus musculus, Rattus norvegicus | H352 | AIALGHPLAGS | 1 | Bos taurus | L152 | TLWAGLTDQHV | 2 | Mus musculus, Rattus norvegicus | L152 | SLWVSLTDQHV | 1 | Homo sapiens | L152 | TLWTGLTDTHV | 1 | Bos taurus | L235 | EQLQKLPPVFK | 1 | Homo sapiens | L235 | EQLQKLPSVFK | 1 | Mus musculus | L235 | EQLQNLPPVFK | 1 | Rattus norvegicus | L235 | EQLNKLPPVFK | 1 | Bos taurus | L354 | ALGHPLGGSGS | 3 | Homo sapiens, Mus musculus, Rattus norvegicus | L354 | ALGHPLAGSGS | 1 | Bos taurus | M161 | HVKLPMGMTAE | 2 | Mus musculus, Rattus norvegicus | M161 | HVQLPMAMTAE | 1 | Homo sapiens | M161 | HVQMPMAITAE | 1 | Bos taurus | M292 | CDPTIMGIGPV | 2 | Mus musculus, Bos taurus | M292 | CDPSIMGIGPV | 1 | Homo sapiens | M292 | CDPAIMGIGPV | 1 | Rattus norvegicus | R224 | VDEHARPQTTL | 3 | Homo sapiens, Mus musculus, Rattus norvegicus | R224 | VDEHPRPQTTM | 1 | Bos taurus | S251 | TAGNASGVSDG | 2 | Mus musculus, Bos taurus | S251 | TAGNASGVADG | 1 | Homo sapiens | S251 | TAGNASGMSDG | 1 | Rattus norvegicus | T227 | HARPQTTLEQL | 3 | Homo sapiens, Mus musculus, Rattus norvegicus | T227 | HPRPQTTMEQL | 1 | Bos taurus | W149 | LEDTLWAGLTD | 2 | Mus musculus, Rattus norvegicus | W149 | LEDSLWVSLTD | 1 | Homo sapiens | W149 | LEDTLWTGLTD | 1 | Bos taurus |
Copyright © 2016-Present - The University of Texas Health Science Center at Houston |